PLATELET-activating factor (PAF) 
Introduction
Platelet-activating factor (PAF, 1-O-alkyl-2-(R)acetyl-sn-glyceryl-3-phosphocholine) is released from endothelial cells and several types of blood ceils in acute allergic and inflammatory reactions ".(for a review see Snyderl). In the whole heart PAF is released under ischaemic conditions. 2 When administered to isolated perfused guinea-pig hearts, PAF reduced the coronary blood flow and exerted negative inotropism. [3] [4] [5] The negative inotropic effect was also seen in isolated papillary muscles 6 and auricular preparations of guinea-pig heart. 7 PAF has also been reported to induce arrhyth-3 mias in isolated Langendorff hearts and in isolated guinea-pig papillary muscles. 9 In guinea-pig ventricular cardiomyocytes PAF has been shown to inhibit single inwardly rectifying K + channels. cardiomyocytes from various regions of the guinea-pig heart and the possible involvement of G-proteins and cyclic AMP in this process.
Materials and Methods
Single cardiomyocytes: Single cardiomyocytes were prepared by the method previously described by Trube and Hescheler. In brief, adult guinea-pigs of either sex (200-250 g) were anaesthetized with ether. The chest was opened, the heart was rapidly removed and washed twice in Tyrode's solution. 1'12 Retrograde perfusion through the aorta was performed at 37C using a Langendorff apparatus. The elapsed time from excision of the heart to cannulation and perfusion was less than 1.5 min.
The heart was perfused with nominally calcium-free (Fig. 5) . A significant reduction of the PAF effect was seen after longer periods of cell dialysis with GDP/gS. After 5-7 min cell dialysis PAF induced a current inhibition of 11 _--F 9% (n 5); after 10-15 min the current was inhibited by 10 8% (n--3, Fig. 5 cyclase. 24 In endothelial cells and platelets it has been demonstrated that PAF receptors inhibit the adenylyl cyclase. 2s '26 To test whether such a mechanism is involved in the inhibition of inwardly rectifying K + currents, a possible involvement of adenosine 3',5'-cyclic monophosphate (cyclic AMP) in the regulation of the current was examined. It was found that direct intracellular application of cyclic AMP (100/.tM in the pipette solution) had no effect on the K + current during [5] [6] [7] [8] [9] [10] 
